Corbus Pharmaceuticals Holdings (CRBP) Prepaid Assets (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Prepaid Assets of $3.0 million in Q4 2025, down 8.75% quarter-over-quarter from $3.3 million in Q3 2025, and down 16.92% on a YoY basis from $3.6 million in Q4 2024.
Corbus Pharmaceuticals Holdings (CRBP) Prepaid Assets (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Prepaid Assets history runs 13 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- In Q4 2025, Prepaid Assets fell 16.92% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (down 16.92% YoY), while the FY2025 annual figure was $3.0 million, down 16.92% from the prior year.
- Prepaid Assets was $3.0 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $3.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.9 million in Q2 2025 to a low of $791616.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $2.4 million across 5 years, with a median of $2.2 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets tumbled 66.53% in 2022, then surged 494.21% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $2.4 million in 2021, then sank by 66.53% to $791616.0 in 2022, then soared by 209.24% to $2.4 million in 2023, then surged by 48.24% to $3.6 million in 2024, then fell by 16.92% to $3.0 million in 2025.
- The last three Prepaid Assets figures came in at $3.0 million (Q4 2025), $3.3 million (Q3 2025), and $5.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 5.95 Mn |
| Mar 31, 2025 | 4.29 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 791,616.00 |
| Sep 30, 2022 | 926,161.00 |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 2.11 Mn |
| Jun 30, 2021 | 2.63 Mn |
| Mar 31, 2021 | 3.66 Mn |